Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Computers and Mathematics with Applications ; 108:196-205, 2022.
Article in English | Scopus | ID: covidwho-1654129

ABSTRACT

Not only coughing and sneezing, but even normal breathing can produce aerosols, because rupture of liquid plugs forms microdroplets during pulmonary airway reopening. Aerosols are important carriers of various viruses, such as influenza, SARS, MERS, and COVID-19. To control airborne disease transmission, it is important to understand aerosol formation, which is related to the pressure drop, liquid plug, and film. In addition, the detrimental pressure and shear stress at the airway wall produced in the process of airway reopening have also attracted a lot of attention. In this paper, we proposed a multiphase lattice Boltzmann method to numerically simulate pulmonary airway reopening, in which the gas-liquid transition is directly driven by the equation of state. After validating the numerical model, two rupture cases with and without aerosol formation were compared and analyzed. We found that injury of the epithelium in the case with aerosol formation was almost the same as that without aerosol formation, even though the pressure drop in the airway increased by about 50%. Further investigation showed that the aerosol size and maximum differences of the wall pressure and shear stress increased with pressure drop in the pulmonary airway. A similar trend was observed when the thickness of the liquid plug became larger, while an opposite trend occurred when the thickness of the liquid film increased. The model can be extended to study generation and transmission of bioaerosols carrying the influenza or coronavirus. © 2022 Elsevier Ltd

2.
J Appl Physiol (1985) ; 130(4): 1143-1151, 2021 04 01.
Article in English | MEDLINE | ID: covidwho-1189943

ABSTRACT

Many patients who suffer from pulmonary diseases cannot inflate their lungs normally, as they need mechanical ventilation (MV) to assist them. The stress associated with MV can damage the delicate epithelium in small airways and alveoli, which can cause complications resulting in ventilation-induced lung injuries (VILIs) in many cases, especially in patients with acute respiratory distress syndrome (ARDS). Therefore, efforts were directed to develop safe modes for MV. In our work, we propose a different approach to decrease injuries of epithelial cells (EpCs) upon MV. We alter EpCs' cytoskeletal structure to increase their survival rate during airway reopening conditions associated with MV. We tested two anti-inflammatory drugs dexamethasone (DEX) and transdehydroandrosterone (DHEA) to alter the cytoskeleton. Cultured rat L2 alveolar EpCs were exposed to airway reopening conditions using a parallel-plate perfusion chamber. Cells were exposed to a single bubble propagation to simulate stresses associated with mechanical ventilation in both control and study groups. Cellular injury and cytoskeleton reorganization were assessed via fluorescence microscopy, whereas cell topography was studied via atomic force microscopy (AFM). Our results indicate that culturing cells in media, DEX solution, or DHEA solution did not lead to cell death (static cultures). Bubble flows caused significant cell injury. Preexposure to DEX or DHEA decreased cell death significantly. The AFM verified alteration of cell mechanics due to actin fiber depolymerization. These results suggest potential beneficial effects of DEX and DHEA for ARDS treatment for patients with COVID-19. They are also critical for VILIs and applicable to future clinical studies.NEW & NOTEWORTHY Preexposure of cultured cells to either dexamethasone or transdehydroandrosterone significantly decreases cellular injuries associated with mechanical ventilation due to their ability to alter the cell mechanics. This is an alternative protective method against VILIs instead of common methods that rely on modification of mechanical ventilator modes.


Subject(s)
Androsterone/therapeutic use , Dexamethasone/therapeutic use , Lung Injury/drug therapy , Respiration, Artificial/adverse effects , Animals , COVID-19/complications , COVID-19/therapy , Cell Death/drug effects , Cells, Cultured , Cytoskeleton/drug effects , Epithelial Cells/drug effects , Lung Injury/etiology , Rats , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL